Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 3/20 | 0.50 |
| ▸ | CNR1 | P21554 | 3/20 | 0.47 |
| ▸ | CNR2 | P34972 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24671773 | 1.00 | BCHE (0.50) | BCHECNR1CNR2RAB9AMEN1 | |
| SCHEMBL2364197 | 0.77 | BCHE (0.62) | BCHECNR1CNR2RAB9AMEN1 | |
| SCHEMBL17294613 | 0.71 | BCHE (0.44) | BCHECNR1CNR2RAB9AMEN1 | |
| SCHEMBL17294719 | 0.71 | BCHE (0.44) | BCHECNR1CNR2RAB9AMEN1 | |
| SCHEMBL22917068 | 0.70 | CNR1 (0.48) | CNR1CNR2RAB9ASLC6A2SLC6A3 | |
| SCHEMBL6432512 | 0.70 | MEN1 (0.68) | CNR1CNR2MEN1KMT2A | |
| SCHEMBL12929309 | 0.69 | CNR1 (0.46) | BCHECNR1CNR2MEN1KMT2A | |
| SCHEMBL12899991 | 0.69 | CNR1 (0.46) | BCHECNR1CNR2MEN1KMT2A | |
| SCHEMBL17294704 | 0.68 | CCR2 (0.54) | KMT2ASLC6A2SLC6A3 | |
| SCHEMBL6432979 | 0.67 | CNR1 (0.69) | CNR1CNR2RAB9AMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3148518-B1 | NOVEL COMPOUNDS AS ANTI-TUBERCULAR AGENTS | SPHAERA PHARMA PRIVATE LTD (IN) | 2022-11-30 | — | — | EP | disclosed |